Trade Summary

4 days ago, Grant Sean, serving as CFO at Vera Therapeutics, Inc. (VERA), sold 4,949 shares at $41.98 per share, for a total transaction value of $207,778.00. Following this transaction, Grant Sean now holds 119,181 shares of VERA.

This sale represents a 4.00% decrease in Grant Sean's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, February 23, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 25, 2026, 2 days after the trade was made.

Vera Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.